| Symbol |
Name |
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4
|
|
AGO1
|
argonaute RISC catalytic component 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
ALKBH3
|
alkB, alkylation repair homolog 3 (E. coli)
|
|
AP2M1
|
adaptor-related protein complex 2, mu 1 subunit
|
|
APOC1
|
apolipoprotein C-I
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARL5B
|
ADP-ribosylation factor-like 5B
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOX1
|
antioxidant 1 copper chaperone
|
|
BCAT2
|
branched chain amino-acid transaminase 2, mitochondrial
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTLA
|
B and T lymphocyte associated
|
|
C3
|
complement component 3
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CCND1
|
cyclin D1
|
|
CCNT1
|
cyclin T1
|
|
CD27
|
CD27 molecule
|
|
CD28
|
CD28 molecule
|
|
CD320
|
CD320 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD5
|
CD5 molecule
|
|
CD99
|
CD99 molecule
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFD
|
complement factor D (adipsin)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CLEC17A
|
C-type lectin domain family 17, member A
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COG4
|
component of oligomeric golgi complex 4
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CP
|
ceruloplasmin (ferroxidase)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYGD
|
crystallin, gamma D
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DMC1
|
DNA meiotic recombinase 1
|
|
DNALI1
|
dynein, axonemal, light intermediate chain 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DOCK8
|
dedicator of cytokinesis 8
|
|
DOHH
|
deoxyhypusine hydroxylase/monooxygenase
|
|
EDA
|
ectodysplasin A
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FAM110B
|
family with sequence similarity 110, member B
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FDCSP
|
follicular dendritic cell secreted protein
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXP1
|
forkhead box P1
|
|
FTMT
|
ferritin mitochondrial
|
|
FXN
|
frataxin
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HAGH
|
hydroxyacylglutathione hydrolase
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBB
|
hemoglobin, beta
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HVCN1
|
hydrogen voltage gated channel 1
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
|
IFNA2
|
interferon, alpha 2
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGL
|
immunoglobulin lambda locus
|
|
IL10
|
interleukin 10
|
|
IL17A
|
interleukin 17A
|
|
IL21
|
interleukin 21
|
|
IL24
|
interleukin 24
|
|
IL4
|
interleukin 4
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ1OT1
|
KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
|
|
KDR
|
kinase insert domain receptor
|
|
KIF5B
|
kinesin family member 5B
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMC2
|
laminin, gamma 2
|
|
LAT
|
linker for activation of T cells
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEPR
|
leptin receptor
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LZTS3
|
leucine zipper, putative tumor suppressor family member 3
|
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
METAP2
|
methionyl aminopeptidase 2
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NPY
|
neuropeptide Y
|
|
NUGGC
|
nuclear GTPase, germinal center associated
|
|
OTX1
|
orthodenticle homeobox 1
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD10
|
programmed cell death 10
|
|
PDHX
|
pyruvate dehydrogenase complex, component X
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PEPD
|
peptidase D
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
POLI
|
polymerase (DNA directed) iota
|
|
PPM1D
|
protein phosphatase, Mg2+/Mn2+ dependent, 1D
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKCQ
|
protein kinase C, theta
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAET1G
|
retinoic acid early transcript 1G
|
|
RBBP5
|
retinoblastoma binding protein 5
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
SCUBE2
|
signal peptide, CUB domain, EGF-like 2
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SERPINB1
|
serpin peptidase inhibitor, clade B (ovalbumin), member 1
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SMG6
|
SMG6 nonsense mediated mRNA decay factor
|
|
SNW1
|
SNW domain containing 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SQSTM1
|
sequestosome 1
|
|
STIM2
|
stromal interaction molecule 2
|
|
STK11
|
serine/threonine kinase 11
|
|
STK24
|
serine/threonine kinase 24
|
|
STK25
|
serine/threonine kinase 25
|
|
STK26
|
serine/threonine protein kinase 26
|
|
SUOX
|
sulfite oxidase
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERT
|
telomerase reverse transcriptase
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TKFC
|
triokinase/FMN cyclase
|
|
TLR2
|
toll-like receptor 2
|
|
TLR5
|
toll-like receptor 5
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TSSC4
|
tumor suppressing subtransferable candidate 4
|
|
ULBP2
|
UL16 binding protein 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
XDH
|
xanthine dehydrogenase
|
|
YBX3
|
Y box binding protein 3
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB17
|
zinc finger and BTB domain containing 17
|
|
ZFYVE21
|
zinc finger, FYVE domain containing 21
|
